Evogene announces positive 2nd year field trial results in corn bio-stimulant ag-biologicals program- | AgroNews
"Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets through the use of a proprietary computational predictive biology platform, announced today highly promising second year field trial results for its bio-stimulant microbial seed treatments for the improvement of corn yield, which are under exclusive license to DuPont Pioneer.
The…
View On WordPress













